PROVIDING YOUR PIPELINES WITH THE SAFETY AND CERTAINTY THEY NEED.
Bringing a novel therapeutic to market requires navigating non-negotiable regulatory milestones regarding safety and ADME profiles—a paradigm that underscores the critical necessity for high-fidelity preclinical DMPK studies.
With a system that is in compliant with U.S. Food and Drug Administration (FDA), European Medical Agency (EMA), and National Medical Products Administration (NMPA) regulations, animal facilities fully accredited by the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC), and highly experienced DMPK team, PharmaLegacy has helped clients worldwide speed up their preclinical drug development.
DMPK studies demand flexibility. Can yours meet their goals?
When it comes to DMPK, flexibility is paramount. The right assay and instrumentation are all critical to ensuring you can meet your study goals and obtain meaningful, clinically relevant data.
Download our DMPK brochure and see how PharmaLegacy is equipped to ensure you get the answers you need, no matter how challenging the study.
Committed to quality:
- FDA part 11 compliant
- Animal studies strictly follow AAALAC and ILAC guidelines
- Electronically managed, traceable research data
- Rigorous adherence to international GLP and QA best practices
- Clients have real-time remote monitoring of studies
